entertainment -WSS

entertainment

author：explore 2025-08-26 10:52:49 - browse：3333

Insitro CEO and founder Daphne Koller Neilson Barnard/Getty Images for The New York Times

SAN FRANCISCO — It took only a single, one-hour meeting in a Starbucks to convince venture capitalist Robert Nelsen that he was going to invest in the company being built by machine-learning whiz Daphne Koller. “She’s just an amazing force of nature,” said Nelsen, who invests for ARCH Venture Partners.

Koller’s company, Insitro, in a matter of months raised over $100 million from big-name investors including ARCH, Foresite Capital, Andreessen Horowitz, and the firm that manages Jeff Bezos’ personal VC investments. (Koller refers to Bezos by his first name.) Now, it’s time for the next step. On Tuesday, the giant drug maker Gilead Sciences said it would pay Insitro $15 million — and up to $1 billion more down the line if it meets certain goals — for help in developing drugs to treat a common liver disease. It is the South San Francisco-based company’s first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.

The very nature of the financials emphasize the exciting but risky reality: The technology has great promise, but nothing is guaranteed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Chinese researcher claims birth of first gene

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

Hilary may become 1st tropical storm to make landfall in California in 84 years

Pregnancy ages women, but effects reverse after delivery

New details revealed about Purdue's marketing of OxyContin

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

ActiGraph execs on goal of drug approvals with digital endpoints

hotspot

entertainment

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Congress must give Medicare recipients genetic counseling access

Novavax promises a turnaround & Lilly roils the obesity market

Medical devices makers are asking for forgiveness, not permission

Supreme Court strikes down use of affirmative action

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Sports medicine is finally prioritizing gender equality

FDA approves first treatment for ultra

entertainment

Medical devices makers are asking for forgiveness, not permission

Diabetes management: Digital health tools fall short, study says

Pregnancy ages women, but effects reverse after delivery

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Eye stem cell transplant could help restore vision in injured people

Patient advocates sound warning on FDA proposal on salt intake

focus

explore

explore

entertainment